Fintel reports that on February 28, 2025, Piper Sandler upgraded their outlook for CAVA Group (NYSE:CAVA) from Neutral to ...

Q4 2024 Management View Chirag Patel, Co-CEO, highlighted Amneal's "stellar financial performance" in 2024, citing double-digit revenue and adjusted EBITDA growth, reduction of net leverage below four ...

When does a rotation become a selloff? Investors may soon find out. For many investors, 2025 has been about switching—from ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Amphastar Pharmaceuticals (AMPH – Research Report), ...

Piper Sandler analyst Michael Lavery maintained a Hold rating on Monster Beverage (MNST – Research Report) today and set a price target of ...

NVDA stock price reacts to Nvidia's latest earnings, with analysts weighing in on AI demand, Blackwell GPU adoption, and ...

Principal Securities Inc. raised its stake in Nextracker Inc. (NASDAQ:NXT – Free Report) by 41.8% during the fourth quarter, ...

First Solar (NASDAQ:FSLR – Get Free Report) had its target price reduced by research analysts at Piper Sandler from $250.00 to $230.00 in a research report issued to clients and investors on Wednesday ...

Guardant Health (NASDAQ:GH – Get Free Report) had its target price upped by Piper Sandler from $34.00 to $50.00 in a report ...

Masimo (NASDAQ:MASI – Get Free Report) had its price objective upped by equities researchers at Piper Sandler from $210.00 to $215.00 in a report released on Wednesday,Benzinga reports. The brokerage ...

Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price target cut by stock analysts at Piper Sandler from $75.00 to $70 ...

Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “outperform” rating reissued by equities research ...